Connecting you to content on EBSCOhost

Works matching IS 11795573 AND DT 2011

Results: 3

1

Long-Term Safety and Tolerability of Open-Label Olanzapine Long-Acting Injection in the Treatment of Schizophrenia: 190-Week Interim Results.

Published in:

Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 37, doi. 10.4137/CMPsy.S6659

By:

McDonnell, David P.;
Andersen, Scott W.;
Detke, Holland C.;
Zhao, Fangyi;
Watson, Susan B.

Publication type:

Article

2

A Retrospective (Post-Marketing) Case Series of Patients Receiving Intramuscular (IM) Olanzapine Outside of Product Doses and Indications (Off-Label): Assessing Safety and Tolerability.

Published in:

Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 1, doi. 10.4137/CMPsy.S6550

By:

Lamoure, Joel W.;
Rudnick, Abraham

Publication type:

Article

3

Generalized Anxiety Disorder in Adults: Focus on Pregabalin.

Published in:

Clinical Medicine Insights: Psychiatry, 2011, n. 3, p. 17, doi. 10.4137/CMPsy.S5069

By:

Boschen, Mark J.

Publication type:

Article